Vaidya Sane Ayurved Laboratories Limited (MADHAVBAUG) Price & Analysis

0 Followers

MADHAVBAUG Stock Chart & Stats

Currently, no data available

Please return soon. This page is being updated.

MADHAVBAUG FAQ

What was Vaidya Sane Ayurved Laboratories Limited’s price range in the past 12 months?

Currently, no data Available

What is Vaidya Sane Ayurved Laboratories Limited’s market cap?

Currently, no data Available

When is Vaidya Sane Ayurved Laboratories Limited’s upcoming earnings report date?

Vaidya Sane Ayurved Laboratories Limited’s upcoming earnings report date is Nov 05, 2026 which is in 66 days.

How were Vaidya Sane Ayurved Laboratories Limited’s earnings last quarter?

Vaidya Sane Ayurved Laboratories Limited released its earnings results on May 15, 2026. The company reported $3.95 earnings per share for the quarter, beating the consensus estimate of N/A by $3.95.

Is Vaidya Sane Ayurved Laboratories Limited overvalued?

According to Wall Street analysts Vaidya Sane Ayurved Laboratories Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Vaidya Sane Ayurved Laboratories Limited pay dividends?

Vaidya Sane Ayurved Laboratories Limited pays a N/A dividend of $0.25 which represents an annual dividend yield of N/A. See more information on Vaidya Sane Ayurved Laboratories Limited dividends here

What is Vaidya Sane Ayurved Laboratories Limited’s EPS estimate?

Vaidya Sane Ayurved Laboratories Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Vaidya Sane Ayurved Laboratories Limited have?

Currently, no data Available

What happened to Vaidya Sane Ayurved Laboratories Limited’s price movement after its last earnings report?

Vaidya Sane Ayurved Laboratories Limited reported an EPS of $3.95 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.

Which hedge fund is a major shareholder of Vaidya Sane Ayurved Laboratories Limited?

Currently, no hedge funds are holding shares in IN:MADHAVBAUG

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Vaidya Sane Ayurved Laboratories Limited

Vaidya Sane Ayurved Laboratories Ltd., operating commercially as Madhavbaug, is an Indian specialist healthcare provider focused on the non-invasive treatment and management of lifestyle-related chronic diseases, primarily cardiac ailments, diabetes, hypertension, obesity, and knee pain. The company integrates traditional Ayurvedic practices with modern medical diagnostics. It operates a network of multidisciplinary clinics and two cardiac hospitals across various Indian states, offering clinical consultations, specialized Ayurvedic procedures, and chronic disease reversal programs. Additionally, the company is involved in the research, development, and sale of proprietary Ayurvedic medicines, health supplements, and wellness products, which are distributed through its clinics, e-pharmacy platform, and online portals. Its target market includes individuals in India suffering from these chronic conditions, leveraging an integrated approach within the chronic care ecosystem.